Hemant Surgical Industries opened higher at ₹650.50, compared with its previous close of ₹647.50. In the last trading session on 12 Nov 2026, the stock traded between ₹640.00 and ₹665.00, with an average traded price of ₹652.98. It showed a sideways intraday trend.
An investment of ₹10,000 made 4 years ago in Hemant Surgical Industries is now worth
₹ 35,973.00
Giving a profit of
₹ 25,973.00 (259.73%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-1.60 (-0.25%)
Day High
₹665.00
Day Low
₹640.00
Day Open
₹650.50
Prev Close
₹647.50
Volume
21,200
Value Traded
₹1.38 Cr
1W Return
6.22%
1M Return
-2.96%
3M Return
78.43%
6M Return
78.52%
1Y Return
122.72%
Market Cap (₹ Cr.)
939
PE Ratio
51.80
PB Ratio
6.00
Dividend Yield
-
ROE
13.22%
ROCE
19.52%
Book Value (₹)
107.89
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
6.22%
6 Weeks
-
1 Month
-2.96%
3 Months
78.43%
9 Months
120.14%
Hemant Surgical AGM resolutions pass with 100% support
All three ordinary resolutions at the 37th AGM passed with 100% votes in favour. Total votes polled stood at 8,292,000, representing 57.04% of outstanding shares. Promoter group voted 100% of their holding (7,680,000 shares) in favour of all items. No dissenting or invalid votes were recorded across any resolution category.
1mo agoHemant Surgical approves FY26 report, schedules 37th AGM
Hemant Surgical Industries approved its Directors' Report for FY26. The 37th AGM is scheduled for September 29, 2026, via video conference. Board meeting concluded on August 29, 2026, in compliance with SEBI regulations.
2mo agoHemant Surgical Industries revises SKD manufacturing agreement terms
Hemant Surgical Industries Limited revised its Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon, USA, detailing the local manufacturing of A-scan and pachymetry devices for the Indian market. The agreement specifies a preferential transfer price excluding taxes and shipping. The disclosure confirms no shareholding or related party transaction status.
5mo agoHemant Surgical acquires 66.66% stake in Lifesenz for ₹19.98 Crores
Hemant Surgical Industries Limited has acquired a 66.66% majority stake in Lifesenz Cancer Research Labs for ₹19.98 Crores, effective June 01, 2026. This strategic move expands the company's presence into precision oncology and personalized cancer treatment solutions. The acquisition is aimed at long-term growth and value creation rather than immediate profitability.
5mo agoHemant Surgical completes Lifesenz acquisition
Hemant Surgical Industries Limited has completed the acquisition of a 66.66% stake in Lifesenz Cancer Research Labs Private Limited for ₹19,99,80,000. The transaction, finalized on June 01, 2026, makes Lifesenz a subsidiary and strengthens the company's presence in cancer diagnostic support services.
5mo agoHemant Surgical Industries Allots 6,49,600 Shares to Singularity Equity Fund 1 After Warrant Conversion
Hemant Surgical Industries has allotted 6,49,600 shares, equating to a 5% stake, to Singularity Equity Fund 1 (Madhusudan Kela) through warrant conversion. Following this allotment, Singularity Equity Fund 1's total shareholding in the company has risen to 6.9%. The transaction marks the completion of warrant conversion by the fund in Hemant Surgical Industries.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,472.20 | +5.60% | ₹16,965.63 | 113.50 | +82.43% | |
| ₹1,667.40 | -1.52% | ₹16,901.01 | 54.30 | -17.67% | |
| ₹525.00 | +4.03% | ₹5,336.46 | 74.10 | +52.62% | |
| ₹319.65 | +2.58% | ₹1,700.74 | 222.90 | +23.46% | |
| ₹511.10 | -7.72% | ₹1,192.30 | 23.20 | +49.01% | |
| ₹206.00 | -0.27% | ₹1,133.61 | 35.10 | -35.90% | |
| ₹462.00 | +0.87% | ₹808.20 | 67.70 | -19.44% | |
| ₹384.00 | -0.97% | ₹683.31 | 23.60 | -39.76% | |
| ₹140.60 | -0.96% | ₹624.98 | 17.70 | -38.63% | |
| ₹174.90 | +0.92% | ₹338.21 | 26.60 | +84.40% | |
| ₹305.00 | +0.78% | ₹291.03 | 61.10 | +11.80% | |
| ₹134.90 | +1.12% | ₹256.85 | 49.60 | -52.32% |
An investment of ₹10,000 made 4 years ago in Hemant Surgical Industries is now worth
₹ 35,973.00
Giving a profit of
₹ 25,973.00 (259.73%)
Note: Past profits do not guarantee future returns.
